|Day Low/High||4.27 / 4.67|
|52 Wk Low/High||3.19 / 9.29|
In trading on Friday, shares of Amyris Inc crossed below their 200 day moving average of $6.58, changing hands as low as $6.33 per share. Amyris Inc shares are currently trading off about 13.4% on the day.
MSFT is never going to be a big time growth stock again.
Investors in Amyris Inc saw new options become available today, for the January 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 465 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Tyson Foods is in the headlines today after it appointed a new CEO.
Go on the offensive rather than turn defensive and miss the opportunities that are developing.
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.
I'm keeping FIVE on the radar but will look for entry after it consolidates a bit.
Despite $5.1 billion deal for Costa, I'm not slurping any KO up.
I expect CRM to regain its footing quickly and challenge highs again soon.
The most recent short interest data was recently released for the 07/31/2018 settlement date, and Amyris Inc is one of the most shorted stocks of the Russell 3000, based on 7.06 "days to cover" versus the median component at 5.19. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 9, Amyris Inc's Director, Patrick Y.
Apple in particular is helping the bullish cause.
HTG Molecular Diagnostics and Amyris are poised for substantial growth.
With indexes within striking distance of their all-time highs in afternoon trading, it's time to take out a little insurance.
If there is any good news on trade the potential for more market upside is strong.
Investors in Amyris Inc saw new options begin trading this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRS options chain for the new July 20th contracts and identified the following put contract of particular interest.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Investors in Amyris Inc saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRS options chain for the new May 18th contracts and identified the following call contract of particular interest.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.